cp 93129 has been researched along with nicotine in 1 studies
| Studies (cp 93129) | Trials (cp 93129) | Recent Studies (post-2010) (cp 93129) | Studies (nicotine) | Trials (nicotine) | Recent Studies (post-2010) (nicotine) |
|---|---|---|---|---|---|
| 109 | 0 | 11 | 28,519 | 2,280 | 9,302 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amtage, F; Birthelmer, A; Cassel, JC; Ehret, A; Förster, S; Jackisch, R; Jeltsch, H; Lehmann, O | 1 |
1 other study(ies) available for cp 93129 and nicotine
| Article | Year |
|---|---|
Neurotransmitter release and its presynaptic modulation in the rat hippocampus after selective damage to cholinergic or/and serotonergic afferents.
Topics: 5,7-Dihydroxytryptamine; Acetylcholine; Adrenergic alpha-Agonists; Animals; Antibodies, Monoclonal; Biogenic Monoamines; Brimonidine Tartrate; Choline O-Acetyltransferase; Cholinergic Agents; Cholinergic Fibers; Electric Stimulation; Hippocampus; Immunotoxins; Male; N-Glycosyl Hydrolases; Neurons, Afferent; Neurotoxins; Nicotine; Nicotinic Agonists; Norepinephrine; Organ Culture Techniques; Pyridines; Pyrroles; Quinoxalines; Rats; Rats, Long-Evans; Ribosome Inactivating Proteins, Type 1; Saporins; Serotonin; Serotonin Agents; Serotonin Receptor Agonists | 2003 |